These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34131867)

  • 1. Living Donor Liver Transplantation During the COVID-19 Pandemic: an Evolving Challenge.
    Bhatti ABH; Nazish M; Khan NY; Manan F; Zia HH; Ilyas A; Ishtiaq W; Khan NA
    J Gastrointest Surg; 2021 Dec; 25(12):3092-3098. PubMed ID: 34131867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restructuring Living-Donor Liver Transplantation at a High-Volume Center During the COVID-19 Pandemic.
    Soin AS; Choudhary NS; Yadav SK; Saigal S; Saraf N; Rastogi A; Bhangui P; Srinivasan T; Mohan N; Saha SK; Gupta A; Chaudhary RJ; Yadav K; Dhampalwar S; Govil D; Gupta N; Vohra V
    J Clin Exp Hepatol; 2021; 11(4):418-423. PubMed ID: 33052181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
    JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC; Fung JY; Pang HH; Leung CK; Li HF; Sin SL; Ma KW; She BW; Dai JW; Chan AC; Cheung TT; Lo CM
    Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y; Wang Q; Yang J; Yan L
    PLoS One; 2015; 10(9):e0136604. PubMed ID: 26378786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T; Moonka D; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S
    Liver Transpl; 2021 Jul; 27(7):971-983. PubMed ID: 33492764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis and meta-regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation.
    Barbetta A; Aljehani M; Kim M; Tien C; Ahearn A; Schilperoort H; Sher L; Emamaullee J
    Am J Transplant; 2021 Jul; 21(7):2399-2412. PubMed ID: 33300241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35.
    Yun SO; Kim J; Rhu J; Choi GS; Joh JW
    J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1293-1303. PubMed ID: 37799067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database.
    Ziogas IA; Alexopoulos SP; Matsuoka LK; Geevarghese SK; Gorden LD; Karp SJ; Perkins JD; Montenovo MI
    Clin Transplant; 2020 Oct; 34(10):e14031. PubMed ID: 33427333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving 400 Living Donor Liver Transplantations Annually During the COVID-19 Pandemic: A Single-Center Experience.
    Kim SM; Yoon YI; Moon DB; Kim KH; Ahn CS; Ha TY; Song GW; Jung DH; Park GC; Kang WH; Cho HD; Jwa E; Ha SM; Na BG; Kim MJ; Kim SH; Yang G; Oh RK; Hwang S; Lee SG
    Transplant Proc; 2024; 56(1):116-124. PubMed ID: 38302403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
    Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
    Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.